Deep understanding of scientific data, for more clarity
With us, you’re on the right track

Integrating insights – easier than ever before

Biomedical data is incredibly plentiful. The challenge is to connect and interpret the information in a meaningful way. Molecular Health software applications and services, based on unique technology and our global knowledge base, enable you to use clinical-molecular drug and disease data for your evidence-based research and decisions.

Our applications help you better understand and predict drug therapy outcomes, clinical trial design, drug-induced adverse events, and drug-drug interactions.

From sequencing data to patient report – in just minutes

MH Guide quickly and accurately identifies and interprets genetic variants in tumors. The MH Guide report helps treatment providers choose therapy options and clinical trials that match the cancer patient’s molecular profile. MH Guide is an IVD medical device approved in the EU.

Find out more

Software-assisted analysis of predisposition to hereditary breast and ovarian cancer syndrome (HBOC)

MH Guide/BRCA supports human geneticists in identifying clinically-significant germline variants associated with hereditary breast and ovarian cancer syndrome (HBOC). This involves automated NGS-based analysis of BRCA1/2 and other HBOC-related genes.

Find out more

The automated analysis of hereditary diseases

MH Guide/Mendel helps human geneticists evaluate NGS-based analyses by automatically identifying clinically-significant genetic variants for hereditary diseases.

Find out more

Predict the technical success of clinical trials

MH Predict supports R&D investment decisions using AI-based predictions of pharmaceutical trial success.

Find out more

Better understanding and prediction of drug-drug interactions

MH Effect can automatically assess the mode of action as well as the safety of medications by analyzing extensive molecular and clinical data.

Find out more

Advanced knowledge for successful research

Molecular Health creates complex disease models, identifies potential targets for drug development, and evaluates indications for new and existing pharmaceuticals.

Find out more

Contact form

Many Thanks!

Your request was successfully sent.